Can You Get Dental Implants With Diabetes Under Control?

For a long period, a diagnosis of diabetes on a medical history form was enough for many practices to decline implant treatment outright. That position has softened considerably, and for good reason: the accumulated evidence points not to the diagnosis but to the degree of metabolic control as the factor that actually influences outcomes.

That is a more useful message, because control is something a patient and their medical team can work on. It is also a more demanding one, because it means the honest answer to "can I have implants?" is often "not yet, and here is what would change that".

This article explains what diabetes does to healing, why HbA1c has become the number that matters, how the relationship with gum disease complicates things, and what a properly adapted treatment plan looks like.

Does diabetes prevent implant treatment?

Diabetes does not in itself prevent implant treatment. Studies comparing patients with well-controlled diabetes to non-diabetic patients report broadly comparable implant survival, though healing may take longer and complications are somewhat more frequent. Poorly controlled diabetes is a different matter: sustained high blood glucose impairs wound healing, reduces the effectiveness of the immune response and is associated with higher rates of infection and early implant failure. Most clinicians therefore assess control rather than diagnosis, commonly using HbA1c alongside the wider medical picture, and will work with your doctor or diabetes team before proceeding.

Several mechanisms are relevant.

Microvascular change. Sustained hyperglycaemia damages small blood vessels, reducing the blood supply that delivers oxygen, nutrients and immune cells to a healing surgical site.

Impaired immune function. Neutrophil function is reduced in poorly controlled diabetes, which affects the ability to contain bacterial contamination at a surgical site.

Advanced glycation end products. Proteins modified by prolonged exposure to glucose accumulate in tissues and promote a chronic inflammatory state, altering how bone and connective tissue behave.

Altered bone turnover. Osteoblast function is affected, which is directly relevant to osseointegration — the process by which bone forms against the implant surface. Our article on the biological changes after implant placement explains what this process involves.

Slower soft tissue healing. Gum healing over a surgical site takes longer, extending the period during which the site is vulnerable.

The practical upshot is not that integration fails, but that it may take longer and be less forgiving of other risk factors stacked alongside it — smoking in particular.

HbA1c reflects average blood glucose over roughly the preceding two to three months, which makes it more informative for surgical planning than a single fingerprick reading.

There is no universally agreed dental threshold, and any figure quoted should be treated as a guide rather than a rule. In broad terms:

• Patients with HbA1c in the range regarded by their medical team as well controlled are generally considered suitable, with standard precautions.

• Moderately raised values usually prompt a discussion about improving control before elective surgery.

• Substantially raised values normally lead to deferral of elective implant treatment while control is addressed.

What matters as much as the number is the trend, the presence of complications elsewhere, and whether the patient is engaged with their diabetes care. Your dentist will usually write to your GP or diabetes team rather than relying on a figure in isolation.

Less than the level of control does. Type 1 diabetes involves autoimmune destruction of insulin-producing cells and typically presents earlier in life; type 2 involves insulin resistance and is more often associated with other cardiovascular risk factors.

For implant planning, the relevant questions are the same for both: how well is glucose controlled, are there complications affecting healing or circulation, what medications are involved, and how stable has control been over time. A well-controlled type 1 patient is in a considerably stronger position than a poorly controlled type 2 patient.

This relationship deserves particular attention because it works in both directions.

Diabetes increases susceptibility to periodontal disease and makes it progress more readily. Periodontal disease, in turn, contributes to systemic inflammation that makes glycaemic control harder to achieve. Treating gum disease has been shown to have a measurable effect on glycaemic control in some patients.

For implant planning this matters enormously, because periodontal disease is the strongest predictor of peri-implant disease later. A diabetic patient with untreated gum disease is not a suitable implant patient until that is addressed. Our gum disease treatment page and our page on periodontitis explain the process, and our article on implants and gum disease covers the sequence in more detail.

• Bring recent HbA1c results and the contact details of your diabetes team.

• Expect written liaison with your GP or consultant before surgery is scheduled.

• Have gum disease treated and stabilised first, with a maintenance interval established.

• Stop smoking. The combination of smoking and diabetes is considerably more concerning than either alone. See our article on implants and smoking.

• Plan the appointment sensibly — morning appointments, eating normally beforehand, bringing glucose testing equipment and something to treat a hypoglycaemic episode.

• Do not alter your medication in anticipation of surgery unless your doctor instructs it. Fasting instructions, if any, must be agreed with your diabetes team.

• Discuss antibiotic and antiseptic measures, which are sometimes used more readily in this group.

Expect a slightly longer, more closely monitored healing period.

• Review appointments are typically more frequent than for a non-diabetic patient.

• The integration period before the crown is fitted may be extended. Our article on what determines the healing phase explains the variables.

• Good glycaemic control during the weeks after surgery matters as much as it did beforehand.

• Any redness, swelling, discharge or discomfort that is increasing rather than settling should be reported without delay.

The NHS provides general information about dental implants at nhs.uk.

• HbA1c substantially above the range agreed with your medical team

• Recent instability, frequent hypoglycaemic episodes or a recent change of regimen

• Active periodontal disease or untreated infection

• Recent cardiovascular event or significant diabetic complications

• Continued smoking where the patient is willing to stop given time

Postponement is not refusal. It is a sequence, and in most cases the intervening work — periodontal treatment, improved control, smoking cessation — benefits the patient regardless of whether implants ultimately follow.

Arrange an assessment if:

• You have diabetes and are considering replacing missing teeth.

• Your gums bleed, are swollen or have receded. See our page on bleeding gums.

• You have been declined implant treatment previously on the basis of your diagnosis alone.

• An existing implant has become sore, loose or the gum around it bleeds.

• You have a dry mouth and are noticing new decay.

• You want a written plan setting out what would need to change before treatment could proceed.

• Control matters more than the diagnosis itself.

• Well-controlled diabetic patients show implant survival broadly comparable to non-diabetic patients.

• Poor control impairs wound healing, immune response and bone formation.

• HbA1c is used as a guide alongside the wider medical picture, not as a single pass mark.

• Type 1 and type 2 are assessed on the same basis: control, complications and stability.

• Diabetes and gum disease influence each other, so periodontal stabilisation comes first.

• Smoking combined with diabetes is a considerably greater concern than either alone.

• Healing may take longer, with more frequent review appointments.

Diabetes reframes implant treatment as a collaboration between the dental team and your medical team rather than as a yes-or-no decision. Where control is good and the gums are healthy, the outlook is encouraging. Where it is not, the honest answer is that the preparatory work comes first — and that work is worth doing in its own right.

If you would like your options assessed and set out in writing, you can arrange an appointment with our team at 22 Wimpole St, London W1G 8GQ, or telephone 020 7183 0692.

Dental symptoms and treatment options should always be assessed individually during a clinical examination.

This article is for general educational information only and is not professional dental advice, diagnosis, or a treatment recommendation. Information here is general and cannot replace an in-person assessment by a qualified, GDC-registered dental professional. Symptoms, suitability, fees, timelines, and outcomes vary according to individual clinical circumstances. If you have pain, swelling, or other concerning symptoms, seek prompt professional dental care. Always request a written treatment plan and cost estimate before proceeding with treatment.

Written Date: 26 August 2026

Next Review Date: 26 August 2027